PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15967518

Autonomic dysfunction in left ventricular hypertrabeculation/noncompaction.

Claudia Stöllberger·Josef Finsterer
View original source ↗Export metadata ↓

Abstract

The findings of Kawasaki et al. [T. Kawasaki, A. Azuma, T. Taniguchi, et al. Heart rate variability in adult patients with isolated left ventricular noncompaction. Int J Cardiol 2005;99:147-150.] raise the following questions: why was dilated cardiomyopathy not investigated? How many of the patients with left ventricular hypertrabeculation/noncompaction (LVHT) showed abnormalities in the resting ECG and in the 24-h-Holter-monitoring? Was there any correlation with extension of LVHT and heart rate variability? Were the patients investigated neurologically and did they show other signs of autonomic dysfunction? To assess vegetative activity in LVHT patients, more comprehensive testing than simply Holter-monitoring is required.

Explore related subjects

Cardiomyopathy, HypertrophicHeart Defects, CongenitalHeart RateHeart VentriclesHumansMyocardial InfarctionCommentLetter

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Claudia Stöllberger, Josef Finsterer. 2005-06-20. Autonomic dysfunction in left ventricular hypertrabeculation/noncompaction.. https://doi.org/10.1016/j.ijcard.2005.05.026

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Percutaneous septal ablation with absorbable gelatin sponge in hypertrophic obstructive cardiomyopathy.

The treatment of the hypertrophic obstructive cardiomyopathy (HOCM) by percutaneous transluminal septal myocardial ablation (PTSMA) with ethanol injection has greatly improved in the last years. This report describes the case of a patient with symptomatic drug-refractory HOCM who underwent an unsuccessful attempt to thrombose the septal artery by PTSMA with alcohol. It has therefore been decided to use small absorbant gelatin sponge (AGS) particles, obtaining immediate thrombotic occlusion of the artery and excellent hemodynamic results with immediate and permanent disappearance of the gradient. The patient progressed satisfactorily and displayed lower than average creatine kinase levels in comparison to the rest of our PTMSA patients. After 2 years of follow-up he still remains asymptomatic and without any gradient. These results suggest that PTSMA with AGS could be a valuable alternative treatment of HOCM.

Cardiomyopathy, Hypertrophic↗
PubMed2006

Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study.

AIMS: Diabetes in pregnant women is increasing and with that the complications in their offspring. We studied our population of diabetic mothers (2003-2005) for pathologic ventricular hypertrophy (PVH). METHODS AND RESULTS: In our retrospective study of all 87 diabetic pregnancies (92 neonates), 16 were type 1, 17 were type 2, and 54 were gestational diabetes (GD). Haemoglobin glycated (HbA1c) median was 5.8% (5.3-6.5): 17 with HbA1c above normal 2 with congenital heart disease (CHD) and six with PVH. A total of 75 neonates were normal, five had CHD, and 12 had PVH (1/12 died post-natally, 1/12 stillborn, 2/12 required premature delivery, 8/12 normal). The 16 type 1 pregnancies resulted in three neonates with CHD and in 50% PVH, including one death, one premature Cesarean section because of PVH. The 17 neonates of type 2 pregnancies showed in one CHD and in 25% PVH. Of the 54 GD pregnancies, one had CHD and one had PVH. CONCLUSION: Pregnancies of both type 1 and 2 diabetes carry an increased risk for foetal development of PVH compared with those with GD. The insufficient effect of preventive glycaemia controls leads to conclude that although no definite predictive parameters for malignant outcome can be presented, close monitoring of these pregnancies may prevent perinatal catastrophes.

Cardiomyopathy, Hypertrophic↗